Related Experiment Video
Updated: May 22, 2026
06:22
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
[Acute respiratory distress syndrome]
M Hecker1, M A Weigand, K Mayer
1Medizinische Klinik II (Pneumologie/internistische Intensivmedizin), Universitätsklinikum Gießen und Marburg, Standort Gießen, Klinikstrasse 33, Gießen, Germany.
Der Internist
|April 25, 2012
Summary
Acute respiratory distress syndrome (ARDS) causes lung injury and hypoxemia. While protective ventilation improves survival, innovative therapies like extracorporeal membrane oxygenation show promise for better outcomes in ARDS patients.
Area of Science:
- Pulmonology
- Critical Care Medicine
- Pathophysiology
Background:
- Acute respiratory distress syndrome (ARDS) is a severe lung injury characterized by hypoxemia.
- Pathophysiology involves alveolar edema, impaired surfactant function, and ventilation-perfusion mismatch.
- Direct and indirect lung injuries can precipitate ARDS.
Purpose of the Study:
- To review the pathophysiology of ARDS.
- To discuss current and emerging therapeutic strategies for ARDS management.
- To highlight the impact of novel therapies on patient survival and outcomes.
Main Methods:
- Literature review of ARDS pathophysiology.
- Analysis of current ARDS management strategies, including mechanical ventilation.
- Evaluation of innovative therapies and their potential clinical impact.
Main Results:
- Protective ventilation is the sole established method to improve ARDS survival.
- Limited success of other therapies in improving oxygenation or reducing ventilation duration.
- Emerging therapies like extracorporeal membrane oxygenation offer potential for improved survival.
Conclusions:
- ARDS remains a critical condition with significant mortality.
- Protective ventilation is crucial for ARDS management.
- Continued research into novel therapies is essential to improve ARDS patient outcomes.
Related Concept Videos
01:23Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...